Search Results
Comparative Data on First Line mCRPC From ASCO GU 2018
ANZUP TheraP Study @ ASCO GU 2021
First-line treatments for patients with mHSPC and mCRPC
OS after progression on first novel hormonal therapy in mCSPC vs mCRPC
WeOncologists ESO Presents: BEST of ASCO GU 2019 by Manuel Maia
2022 ASCO GU Cancers Symposium Keynote | A Path Forward: Addressing Disparities in GU Cancers
Uro-Onc data at ESMO 2018: what to look out for
GU Cancers: Best of ASCO - M. Milowsky - 20180425
Phase II results of olaparib and abiraterone for mCRPC
Prostate Cancer | Investigators Discuss Available Research Guiding the Care of Patients with Pros...
ASCO 2018: Novel treatment strategies in prostate cancer therapeutics
USANZ Session at #BAUS21
